Search company, investor...



Series B | Alive

Total Raised


Last Raised

$6M | 21 yrs ago

About enumerate

Developer and marketer of software for presenting numerical data in an interactive format. The company's core product enables business users to easily publish reports from a variety of different data sources for both internal corporate use and external communication. The interactive reports enable end-users to instantly analyze the data and make critical business decisions. [Keywords: numerical content, interactive data, performance metrics, business reporting]

Headquarters Location

7927 Jones Branch Drive Suite 600 North

McLean, Virginia, 22102,

United States


Missing: enumerate's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: enumerate's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

enumerate Frequently Asked Questions (FAQ)

  • Where is enumerate's headquarters?

    enumerate's headquarters is located at 7927 Jones Branch Drive, McLean.

  • What is enumerate's latest funding round?

    enumerate's latest funding round is Series B.

  • How much did enumerate raise?

    enumerate raised a total of $17M.

  • Who are the investors of enumerate?

    Investors of enumerate include The Carlyle Group.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.